PURPOSE: To investigate the effect of metabolic syndrome (MetS) on the response to medical therapy of benign prostatic hyperplasia (BPH) after a 3-month period of treatment. MATERIALS AND METHODS: This was a cohort study of 100 patients, 47 with MetS and 53 without MetS, referred to either the primary care unit or referral hospital with BPH who had moderate lower urinary tract symptoms of prostate involvement and were candidates for medical treatment. Our main outcome was response to medical treatment with prazosin 1 mg twice a day and finasteride 5 mg daily in patients with BPH on the basis of International Prostate Symptom Score (IPSS). Multivariate analysis of covariance was used to compare BPH treatment response in patients with and without MetS before and after receiving treatment. RESULTS: The mean volume of the prostate was significantly higher in MetS patients than in patients without MetS (57+/-32.65 mL compared with 46.00+/-20.19 mL, p=0.036). The control group demonstrated an 11-unit reduction in IPSS, whereas those with MetS showed a reduction in the symptom score of only 6 units (p<0.001). Regarding the components of MetS separately, triglyceride (p<0.001), fasting blood sugar (p=0.001), and waist circumference (p=0.028) significantly affected the clinical progression of BPH. The observational nature of this study may be a limitation in comparison with an interventional study. CONCLUSIONS: The results of the present study showed that MetS can negatively affect the response to medical treatment of BPH. Therefore, it is necessary to consider MetS in selecting patients with BPH for drug therapy.
Aged ; Case-Control Studies ; Finasteride/*therapeutic use ; Humans ; Lower Urinary Tract Symptoms/etiology ; Male ; Metabolic Syndrome X/*complications ; Middle Aged ; Patient Selection ; Prazosin/*therapeutic use ; Prostatic Hyperplasia/complications/*drug therapy/pathology ; Treatment Outcome ; Urological Agents/*therapeutic use

OBJECTIVE: The aim of this study was to determine the association between the incidence of and mortality due to corpus uteri cancer (CUC) and the human development index (HDI) across the world.METHODS: This was an ecological study. The incidence and mortality rates of CUC along with HDI data were extracted from the Global Cancer Data in 2018. Subsequently, correlation coefficient and linear regression model were used to determine the association between the incidence and mortality rates of CUC and the HDI. STATA-14 was used for data analysis.RESULTS: There was a positive and significant correlation between the incidence (r=0.693; P<0.001) and mortality (r=0.284; P<0.001) rates of uterine cancer and the HDI. A positive and significant correlation was also observed between the incidence rate and the gross national income per 1,000 capita (r=0.440; P<0.001), mean years of schooling (MYS) (r=0.740; P<0.001), life expectancy at birth (LEB) (r=0.590; P<0.001), and expected years of schooling (r=0.650; P<0.001). The results of the linear regression model showed a significant statistical association between MYS and the incidence of CUC (β=1.10; 95% confidence interval [CI], 0.60–1.70) and LEB and mortality due to uteri cancer (β=0.40; 95% CI, 0.10–0.90).CONCLUSION: The results of this study suggest a significant statistical association between the incidence and mortality rates of CUC and the HDI.

Objective: Anemia is a major problem in developing countries, the purpose of the present study was to investigate the relationship between the human development index (HDI) and the prevalence of anemia among Asian women. Methods: This was a descriptive-analytic ecological study. The study analyzed data including HDI and prevalence of anemia extracted from the World Bank. The correlation coefficient and analysis of variance were used for data analysis. The significance level was considered to be less than 0.05. Analyses were performed using Stata-14 software. Results: The results revealed that the prevalence of anemia in women of reproductive age (R=−0.626, P<0.001), pregnant women (R=−0.576, P<0.001) and non-pregnant women (R=−0.623, P<0.0001) was significantly negatively correlated with HDI index. In the analysis of HDI components and the prevalence of anemia, a significant negative correlation was observed between the prevalence of anemia and the mean years of schooling, life expectancy at birth, and expected years of schooling indices in all 3 groups of women (non-pregnant, pregnant, and of reproductive age) (P<0.05). Conclusion Since there was a negative correlation between the prevalence of anemia in women and HDI, paying greater attention to factors which influence anemia may contribute to the prevention of anemia in developing countries.

Objective: Anemia is a major problem in developing countries, the purpose of the present study was to investigate the relationship between the human development index (HDI) and the prevalence of anemia among Asian women. Methods: This was a descriptive-analytic ecological study. The study analyzed data including HDI and prevalence of anemia extracted from the World Bank. The correlation coefficient and analysis of variance were used for data analysis. The significance level was considered to be less than 0.05. Analyses were performed using Stata-14 software. Results: The results revealed that the prevalence of anemia in women of reproductive age (R=−0.626, P<0.001), pregnant women (R=−0.576, P<0.001) and non-pregnant women (R=−0.623, P<0.0001) was significantly negatively correlated with HDI index. In the analysis of HDI components and the prevalence of anemia, a significant negative correlation was observed between the prevalence of anemia and the mean years of schooling, life expectancy at birth, and expected years of schooling indices in all 3 groups of women (non-pregnant, pregnant, and of reproductive age) (P<0.05). Conclusion Since there was a negative correlation between the prevalence of anemia in women and HDI, paying greater attention to factors which influence anemia may contribute to the prevention of anemia in developing countries.